Heritability for plasma VEGF concentration in the Stanislas family study

Annals of Human Genetics

Volumn 71, Issue 1, 2007, Pages 54-63

  Berrahmoune, Hind ^a,c   Herbeth, Bernard ^a,c   Lamont, John V ^b   Masson, Christine ^a,c   Fitzgerald, Peter S ^b   Visvikis Siest, Sophie ^a,c  

^a INSERM   (France)

^b Randox Laboratories Ltd   (United Kingdom)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Family resemblance; Genetics; Heritability; Polymorphisms; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; MALE; NUCLEAR FAMILY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY HEALTH; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NUCLEAR FAMILY; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845267785     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2006.00298.x     Document Type: Article

References (33)

1. Awata, T. et al. (2002) A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51, 1635-1639.
2. Awata, T. et al. (2005) Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 333, 679-685.
3. Barleon, B. et al. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
4. Berrahmoune, H. et al. (2006) Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort. Clin Chem 52, 504-510.
5. Celletti, F. L. et al. (2001) Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7, 425-429.
6. Clauss, M. et al. (1990) Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172, 1535-1545.
7. Del Bo, R. et al. (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57, 373-380.
8. Donner, A. & Koval, J. J. (1981) A multivariate analysis of family data. Am J Epidemiol 114, 149-154.
9. Ferrara, N. (1999) Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56, 794-814.
10. Fitzgerald, S. P. et al. (2005) Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 51, 1165-1176.
11. Harrela, M. et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98, 2612-2615.
12. Jin, Q. et al. (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11, 3647-3653.
13. Lange, K. et al. (1988) Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet. Epidemiol 5, 471-472.
14. Lange, K. et al. (1976) Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 39, 485-491.
15. Lemstrom, K. B. et al. (2002) Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 105, 2524-2530.
16. Li, H. J. et al. (2005) A twin study for serum leptin, soluble leptin receptor, and free insulin-like growth factor-I in pubertal females. J Clin Endocrinol Metab 90, 3659-3664.
17. Li, L. et al. (2004) Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res 24, 1973-1979.
18. Livshits, G. (2005) Genetic epidemiology of skeletal system aging in apparently healthy human population. Mech Ageing Dev 126, 269-279.
19. Pantsulaia, I. et al. (2004) Heritability of circulating growth factors involved in the angiogenesis in healthy human population. Cytokine 27, 152-158.
20. Ponthieux, A. et al. (2004) Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: The Stanislas study. Atherosclerosis 172, 299-308.
21. Renner, W. et al. (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37, 443-448.
22. Senger, D. R. et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
23. Siest, G., Visvikis, S., Herbeth, B., Gueguen, R., Vincent-Viry, M., Sass, C., Beaud, B., Lecomte, E., Steinmetz, J., Locuty, J. & Chevrier, P. (1998) Objectives design of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas cohort. Clin Chem Lab Med 36, 35-42.
24. Stevens, A. et al. (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63, 812-816.
25. Storkebaum, E. et al. (2004) VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26, 943-954.
26. Takano, S. et al. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56, 2185-2190.
27. Tiret, L. et al. (1991) Testing for association between disease and linked marker loci: A log-linear-model analysis. Am J Hum Genet 48, 926-934.
28. Tischer, E. et al. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266, 11947-11954.
29. Tregouet, D. A. et al. (2002) Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11, 2015-2023.
30. Tregouet, D. A. et al. (2004) A new algorithm for haplotype-based association analysis: The Stochastic-EM algorithm. Ann Hum Genet 68, 165-177.
31. van der, M. P. et al. (2005) The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: A MERIT-HF substudy. J Card Fail 11, 279-284.
32. Watson, C. J. et al. (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 12, 1232-1235.
33. Zhao, Q. et al. (2002) Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105, 1110-1115.